This is Episode 19a, the first in our new two-part series on a fascinating and challenging benign condition: Arteriovenous Malformations, or AVMs. To build a foundational understanding of arteriovenous malformations (AVMs) by covering their biology and risk factors, applying the Spetzler-Martin scale to assess surgical risk, calculating annual hemorrhage risk, and critically dissecting the controversial ARUBA trial.